Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-11

Clinical Trial Update: Role of Fenofibrate in Neonatal Jaundice [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating fenofibrate for neonatal jaundice has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Ain Shams University | Conditions: Neonatal Jaundice | Phase 4 | Status: COMPLETED